BAM15 Caps (50mg)

BAM15 is a synthetic mitochondrial protonophore studied for its ability to uncouple mitochondrial respiration from ATP production, a mechanism examined in metabolic and obesity research. This capsule format delivers BAM15 in a stabilized oral dosage form for laboratory research use.

Researchers study BAM15 primarily for its interaction with mitochondrial membrane potential and cellular energy expenditure pathways associated with fat metabolism.

GENIQ supplies BAM15 Caps strictly for laboratory research only—not for human or animal use.

$299.99

Categories: ,
  • Official retailer
  • Quality guaranteed
  • Free delivery from $99
  • Free returns is available

What Is BAM15 Caps?

BAM15 is a synthetic mitochondrial protonophore studied for its ability to uncouple mitochondrial respiration from ATP production, a mechanism examined in metabolic and obesity research. This capsule format delivers BAM15 in a stabilized oral dosage form for laboratory research use. Researchers study BAM15 primarily for its interaction with mitochondrial membrane potential and cellular energy expenditure pathways associated with fat metabolism. GENIQ supplies BAM15 Caps strictly for laboratory research only—not for human or animal use.

Peptide Overview

BAM15 is frequently studied in research focused on mitochondrial uncoupling, energy expenditure, and metabolic regulation. In controlled laboratory environments, researchers examine how BAM15 Caps may promote changes in:

Mitochondrial membrane uncoupling activity
Cellular energy expenditure markers
Fat-oxidation metabolic pathways
Insulin-sensitivity research models
Reactive oxygen species (ROS) signaling
Body-composition research protocols
Diet-induced obesity research models

All findings remain limited to preclinical and in-vitro experimental environments.

History of BAM15

BAM15 was identified through a screening program at Virginia Tech and Baylor College of Medicine searching for chemical uncouplers with an improved safety margin compared to earlier mitochondrial uncouplers such as DNP. Scientists found that BAM15 dissipates the mitochondrial proton gradient without the toxicity seen in older compounds. Because of this interaction, BAM15 became a compound of interest in studies involving:

Mitochondrial uncoupling pharmacology
Diet-induced obesity research models
Insulin resistance and glycemic control
Energy metabolism and thermogenesis
Non-toxic uncoupler screening research
Metabolic disease research models

Peptide Structure

Chemical Name: N5,N6-bis(2-fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine (BAM15) Classification: Mitochondrial protonophore / chemical uncoupler Form Supplied: Oral capsule, 50mg per capsule (60 capsules per bottle)

Certificates of Analysis

Every batch of GENIQ BAM15 Caps is verified by third-party laboratory testing confirming identity, purity, and capsule content accuracy. Certificates of Analysis (COA) are available upon request for research verification.

Research Findings

Research involving BAM15 commonly focuses on:

Mitochondrial uncoupling: Studies evaluate proton-gradient dissipation and respiration changes.
Energy expenditure markers: Researchers investigate increases in metabolic rate independent of activity levels.
Insulin sensitivity: Laboratory models track glycemic control outcomes in diet-induced obesity models.
Fat-oxidation pathways: Experimental studies analyze lipid metabolism changes following uncoupling.
Safety-margin comparisons: Investigations compare BAM15 to earlier uncouplers regarding toxicity profiles.

These findings reflect laboratory experiments only and do not indicate clinical outcomes.

References

1. Alexopoulos S.J., et al. Mitochondrial Uncoupler BAM15 Reverses Diet-Induced Obesity and Insulin Resistance in Mice. Nature Communications. 2. Kenwood B.M., et al. Identification of a Novel Mitochondrial Uncoupler That Does Not Depolarize the Plasma Membrane. Molecular Metabolism. 3. Virginia Tech Fralin Life Sciences Institute. BAM15 Mitochondrial Uncoupling Research Program.

FAQ

What type of research is BAM15 Caps used for?

BAM15 Caps is commonly used in studies involving mitochondrial uncoupling, energy expenditure, and metabolic research.

Yes. Every GENIQ compound includes a COA verifying identity and purity.

No. BAM15 is not FDA-approved and is intended strictly for laboratory research, not for human or animal administration.

No. GENIQ does not provide dosing, administration, or preparation instructions, as our compounds are supplied strictly for laboratory research.

BAM15 Caps should only be handled by qualified researchers and laboratory professionals trained in proper handling procedures.

Research Use Only

All GENIQ compounds are intended strictly for laboratory research.
 Not for human or animal consumption, medical use, or therapeutic application.

Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.

BAM15 is a synthetic mitochondrial protonophore studied for its ability to uncouple mitochondrial respiration from ATP production, a mechanism examined in metabolic and obesity research. This capsule format delivers BAM15 in a stabilized oral dosage form for laboratory research use.

Researchers study BAM15 primarily for its interaction with mitochondrial membrane potential and cellular energy expenditure pathways associated with fat metabolism.

GENIQ supplies BAM15 Caps strictly for laboratory research only—not for human or animal use.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.